Search

Your search keyword '"Scott T. Miller"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Scott T. Miller" Remove constraint Author: "Scott T. Miller"
221 results on '"Scott T. Miller"'

Search Results

101. A pressure-based, compressible, two-phase flow finite volume method for underwater explosions

102. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases

103. Discontinuing penicillin prophylaxis in children with sickle cell anemia

104. Phase 3 Study of L-Glutamine Therapy in Sickle Cell Anemia and Sickle β0-Thalassemia Subgroup Analyses Show Consistent Clinical Improvement

105. Iron Unloading By Therapeutic Phlebotomy in Previously Transfused Children with Sickle Cell Anemia: The Twitch Experience

106. Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

107. Priapism in Children with Sickle Cell Disease

108. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions

109. A spacetime finite element method for coupled acoustic fluid-structure interactions

110. Red Blood Cell Alloimmunization in Sickle Cell Disease: Prevalence in 2010

111. Inpatient Management of Sickle Cell Pain: a Snapshot of Current Practice

112. The Hetu'u Global Network: Measuring the Distance to the Sun Using the June 5th/6th Transit of Venus

113. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)

114. Prevalence of Lymphopenia in Children with AIDS

115. Opioid Patient Controlled Analgesia (PCA) use during the Initial Experience with the IMPROVE PCA Trial: A Phase III Analgesic Trial for Hospitalized Sickle Cell Patients with Painful Episodes

116. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia

117. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

118. Massive accidental overdose of hydroxyurea in a young child with sickle cell anemia

119. How I treat acute chest syndrome in children with sickle cell disease

120. G6PD deficiency and stroke in the CSSCD

121. The Immersed Boundary Method for Water Entry Simulation

122. A Tightly-Coupled, Semi-Implicit CFD Approach for All-Mach Number Flows

123. Contributors

124. Skeletal muscle metastasis in a patient with wilms tumor and multiple late recurrences

125. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload

127. A short course of prednisone in the management of acute chest syndrome of sickle cell disease

128. Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial

129. The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design

130. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease

131. Severe Anemia due to B19 Parvovirus Infection in Children with Acute Leukemia in Remission

132. Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease

133. TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

134. Effects of Genetic Polymorphisms on Leukocyte and Neutrophil Counts and Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia

135. Acoustic ground cloaks revisited

136. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results

137. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial

138. B19 Parvovirus Infection and Transient Aplastic Crisis in a Child with Sickle Cell Anemia Concomitant Bone Marrow/Bone Infarction and Acute Chest Syndrome

139. Anti-pneumococcal antibody levels three to seven years after first booster immunization in children with sickle cell disease, and after a second booster

140. DAK, a new low-incidence antigen in the Rh blood group system

141. Extraplanar Emission-Line Gas in Edge-On Spiral Galaxies. II. Optical Spectroscopy

142. Extraplanar Emission-Line Gas in Edge-On Spiral Galaxies. I. Deep Emission-Line Imaging

143. B19 parvovirus infection in children with malignant solid tumors receiving chemotherapy

144. Hemophagocytosis and granulomas in the bone marrow of a child with Down syndrome

145. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia

146. Prediction of adverse outcomes in children with sickle cell disease

147. Biconical Outflow in the Seyfert Galaxy NGC 2992

148. A fast hemoglobin variant on newborn screening is associated with alpha-thalassemia trait

149. Acute chest syndrome, transfusion, and neurologic events in children with sickle cell disease

150. Fatal pneumococcal septicemia in hemoglobin SC disease

Catalog

Books, media, physical & digital resources